Arcus Biosciences, Inc. · NYSE:RCUS
BlackRock, Inc. reported a 10.40% stake in Arcus Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 8, 2026
BlackRock, Inc. reported a 10.40% stake in Arcus Biosciences, Inc., 12,736,927 shares, as a passive investor on Dec 31, 2025. Filed Jan 8, 2026 (Schedule 13G/A).
- Stake
- 10.40%
- Shares
- 12,736,927
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 10.40% | 12,736,927 |
Source
Related
- Arcus Biosciences, Inc.
- BlackRock, Inc.
- Arcus Biosciences, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Form 4 · Azoy Alexander · Aug 24, 2026
- Schedule 13D/A · Gilead Sciences, Inc. · Aug 7, 2026
- Form 4 · Jaen Juan C. · Jul 13, 2026
- Form 4 · Jaen Juan C. · Jun 24, 2026
- Form 4 · Lambert Nicole · Jun 12, 2026